Articles
What it costs, what you are on the hook for, and how the parts that are not the storefront actually work. Written to answer the question in the title, in the first paragraph.
-
Can you still sell compounded semaglutide or tirzepatide?
The shortages ended, the compounding exemption went with them, and the FDA has sent three waves of warning letters to telehealth companies. What a 503A pharmacy may still compound, what the letters actually cited, and what a brand should sell instead.
Read -
Retatrutide: what a telehealth brand needs to know before selling it
Retatrutide is the most searched molecule in weight loss and one of the few you cannot lawfully sell. It is not approved, not in shortage, and not compoundable, and the FDA has already warned telehealth companies marketing it.
Read -
What gets a telehealth company an FDA warning letter
The letters sent to telehealth sellers since 2025 are not about the medicine. They are about the website. The specific sentences the FDA cited, what the agency said back, and how to audit your own pages before someone else does.
Read -
Which telehealth categories still have margin in 2026
Generic GLP-1 weight loss and commodity men's health are crowded and discounting. Where the room actually is now: testosterone, hormone therapy and menopause, longevity, and anything that sells a programme rather than a vial.
Read -
Which states should you launch a telehealth brand in?
Launching in all fifty states on day one is the most common and most expensive mistake. How licensure actually works, what the Interstate Medical Licensure Compact does and does not cover, and how to choose the first three.
Read -
How to start a TRT telehealth brand
Testosterone is one of the few categories still growing, and the one with the most constraints people discover late: controlled scheduling, no refill path, labs, and far fewer states than you expect.
Read -
LegitScript certification: what it costs and why your ads need it
Google and Meta will not run prescription telehealth ads without LegitScript certification, and then their own healthcare approval on top. What it costs in 2026, what the reviewers look at, and what to fix before you apply.
Read -
Do you need a medical licence to start a telehealth brand?
In most states a company owned by non-clinicians cannot own the medical practice. What the MSO and friendly PC structure is, why states are enforcing it harder in 2026, and the questions to take to a healthcare lawyer.
Read -
Why telehealth brands get dropped by payment processors
Card networks class telemedicine as high risk, several mainstream processors restrict it outright, and the chargeback threshold tightened in April 2026. What that means for a prescription brand, and why a backup gateway is not optional.
Read -
Can you sell prescriptions on Shopify?
Shopify does not sign BAAs and its acceptable use policy prohibits protected health information. What that rules out, what a hybrid setup actually costs you, and what a prescription store needs that a commerce platform does not have.
Read -
HHS just opened six peptides for compounding. What it means for a telehealth brand
On October 30, 2026 HHS published an interim policy allowing 503A pharmacies and physicians to compound BPC-157, TB-500, Epitalon, KPV, MOTS-c and Semax under strict conditions. What changed, what did not, and what a brand that wants to sell them needs in place.
Read -
How to start a peptide telehealth brand, step by step
The order of operations for launching a peptide brand online under the October 2026 HHS policy: which peptides you can sell, the entity and licensing questions, the prescriber, the pharmacy and its paperwork, the store, pricing, ads and the launch.
Read -
Peptide marketing: what your store can and cannot say
The six HHS peptides are not FDA approved and have no trial to cite, so every word on the product page is a claim you have to defend. The lines that are safe, the lines that are not, the FTC rules behind them, and the ad platform policies on top.
Read -
White label telehealth: what "your own domain" actually requires
What it takes to run a telehealth storefront on your own domain: DNS records, SSL, sending patient email from your domain, and the parts of white labelling that have nothing to do with the logo.
Read -
Why telehealth subscriptions churn, and what the refill flow has to do about it
Most prescription subscription cancellations are operational, not clinical: a refill that needed a new intake and nobody asked, a card that failed silently, a shipment with no tracking. What the refill flow has to handle.
Read -
HIPAA for a telehealth store: what a BAA actually covers
What a business associate agreement does and does not cover for a direct-to-consumer telehealth brand, where protected health information leaks in practice, and the questions to ask a platform.
Read -
How to choose a telehealth platform: 12 questions worth asking
The questions that separate telehealth platforms once the feature lists stop being useful: pricing shape, data portability, who owns the patient relationship, and what happens when you want to leave.
Read -
Do you need your own doctors and pharmacy to sell prescriptions online?
No, and here is what the alternative actually involves: how a provider network covers 50 states, how pharmacy routing works, what you are responsible for, and what it means to bring your own relationships.
Read -
What does it cost to start a telehealth brand?
A line-by-line account of what a prescription telehealth brand actually pays to launch and run: platform, provider visits, medication, pharmacy, payments and the fees some platforms take from revenue.
Read